Characterization of Ggrb4, an adapter protein interacting with Bcr-Abl.
We report here the characterization of an adapter protein identified in a yeast 2-hybrid screen with the use of Bcr-Abl as the bait. Grb4 bound to Bcr-Abl in a variety of systems, both in vitro and in vivo, and is an excellent substrate of the Bcr-Abl tyrosine kinase. The association of Grb4 and Bcr-Abl in intact cells was mediated by an src homology (SH)2-mediated phosphotyrosine-dependent interaction as well as an SH3-mediated phosphotyrosine-independent interaction. Grb4 has 68% homology to the adapter protein Nck and has similar but distinct binding specificities in K562 lysates. Subcellular localization studies indicate that Grb4 localizes to both the nucleus and the cytoplasm. Coexpression of kinase-active Bcr-Abl with Grb4 resulted in the translocation of Grb4 from the cytoplasm and the nucleus to the cytoskeleton to colocalize with Bcr-Abl. In addition, expression of Grb4 with kinase-active Bcr-Abl resulted in a redistribution of actin-associated Bcr-Abl. Finally, coexpression of Grb4 and oncogenic v-Abl strongly inhibited v-Abl-induced AP-1 activation. Together, these data indicate that Grb4 in conjunction with Bcr-Abl may be capable of modulating the cytoskeletal structure and negatively interfering with the signaling of oncogenic Abl kinases. Grb4 may therefore play a role in the molecular pathogenesis of chronic myelogenous leukemia. (Blood. 2000;96:618-624) (Blood. 2000;96:618-624)
Coutinho
S
S
Department of Internal Medicine III, Technical University of Munich; Medical Institute for Radiation and Cell Research, Würzburg, Germany.
Jahn
T
T
Lewitzky
M
M
Feller
S
S
Hutzler
P
P
Peschel
C
C
Duyster
J
J
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D019556:COS Cells; D002467:Cell Nucleus / Q000378:metabolism; D003001:Cloning, Molecular; D016044:Fusion Proteins, bcr-abl / Q000378:metabolism*; D005982:Glutathione Transferase; D015513:Oncogene Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D016374:Oncogene Proteins v-abl / Q000494:pharmacology; D010446:Peptide Fragments / Q000235:genetics; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D018808:Transcription Factor AP-1 / Q000378:metabolism
D048868:Adaptor Proteins, Signal Transducing; C078332:Nck protein; D015513:Oncogene Proteins; D016374:Oncogene Proteins v-abl; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; D018808:Transcription Factor AP-1; D019000:Phosphotyrosine; D005982:Glutathione Transferase; D016044:Fusion Proteins, bcr-abl